We improve sepsis management by empowering clinicians to appropriately treat patients suspected of bloodstream infections faster than ever before. T2Direct Diagnostics™ are the first FDA-cleared tests that identify sepsis-causing pathogens in 3-5 hours--without waiting for blood culture--enabling early targeted therapy which may prevent the progression to sepsis.